Blood plasma immunoregulation medicament capsule
A technology of immunomodulatory drugs and plasma, applied in capsule delivery, drug combination, antipyretics, etc., can solve the problems of toxic side effects, short half-life, etc., achieve the goal of improving the internal environment, anti-immune damage internal environment, and improving immune defense Effect
Inactive Publication Date: 2008-08-13
刘晓清
View PDF0 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0011] However, due to the short half-life of cytokine drugs in the human body, it is necessary to give patients high doses of repeated injections to achieve a certain effect, and this practice often leads to serious side effects
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0022] Take fresh plasma containing 1000mg of total plasma protein and add it to 800mL eggs, stir evenly, dry and crush into egg powder, fill it into No. Protein 1mg.
Embodiment 2
[0024] Take fresh plasma containing 500g plasma total protein and add it to 800mL eggs, stir evenly, dry and crush into egg powder, fill it into No. Protein 500mg.
Embodiment 3
[0026] Take fresh plasma containing 100g of total plasma protein and add it to 800mL eggs, stir evenly, dry and pulverize into egg powder, fill it into No. Protein 100mg.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more
Abstract
The invention relates to a medicine capsule used for adjusting the plasma immunity. Each of the medicine dose unit contains 1 to 500mg plasma protein. The medicine takes a poultry egg as an adhesive agent. The fresh plasma is added into the poultry egg for full agitation, then dried and crushed into powder, and then the powder is added into the capsules. The medicine capsule can stimulate the immunity action, thus achieving the aim of health care and curing and preventing diseases. As the amount of the effective ingredients is small, no adverse drug reaction is occurred. Seen through the treatment to body aches, bronchial asthma, epilepsy, inflammatory aches, Meniere disease, etc., the capsule achieves good result.
Description
technical field [0001] The present invention relates to an immunoregulatory drug, in particular to an immune modulatory drug made from blood plasma. The medicine of the present invention can induce and stimulate the immune response of the human body to resist and treat diseases. Background technique [0002] Cytokines are a general term for biologically active protein substances produced by cells. Cytokines are given to the body as drugs through various channels, and the biological effects of cytokines can be fully exerted, which can be used to resist and treat diseases. By inducing and stimulating the immune response of Peyer's patches-associated lymphoid tissue in the intestinal system, the following effects can be obtained by using a reasonable dose and combination of trace cytokines: [0003] 1. Anti-inflammatory effect [0004] It can inhibit inflammation caused by bacterial infection, immune, chemical, radiation and physical factors. Similar to glucocorticoids, it ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/16A61K47/42A61K9/48A61P37/02A61P29/00A61P25/08A61P25/18A61K47/46
Inventor 刘晓清
Owner 刘晓清
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap